SCHEMBL16347136

SCHEMBL16347136

CC(C)(O[Si](C)(C)C)c1ccnn1Cc1cccc(Br)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.41
ADRA2C P18825 1/20 0.41
CYP11B2 P19099 1/20 0.41
XDH P47989 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
IDO1 P14902 3/20 0.37
TDO2 P48775 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.37
GPR55 Q9Y2T6 1/20 0.37
CYP19A1 P11511 3/20 0.36
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
AGXT P21549 2/20 0.35
RIPK1 Q13546 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16347299 0.79 MEN1 (0.39) CYP11B1ADRA2CCYP11B2XDHMEN1
SCHEMBL1525587 0.69 CA1 (0.40) MEN1KMT2ASMN1; SMN2IDO1CA9
SCHEMBL22951232 0.67 KDM4E (0.47) MEN1KMT2ASMN1; SMN2CYP19A1LMNA
SCHEMBL16102428 0.66 CYP19A1 (0.59) CYP11B1ADRA2CCYP11B2XDHMEN1
SCHEMBL16347240 0.66 XDH (0.50) CYP11B1ADRA2CCYP11B2XDHMEN1
SCHEMBL16347390 0.65 XDH (0.41) CYP11B1ADRA2CCYP11B2XDHMEN1
SCHEMBL8963480 0.65 IDO1 (0.43) CYP11B1ADRA2CCYP11B2XDHMEN1
SCHEMBL18295112 0.64 MEN1 (0.44) CYP11B1ADRA2CCYP11B2XDHMEN1
SCHEMBL27751967 0.64 MEN1 (0.43) CYP11B1ADRA2CCYP11B2XDHMEN1
SCHEMBL29700069 0.63 PTGER1 (0.51) MEN1KMT2APTGDR2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3016934-A2 HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME Millennium Pharmaceuticals, Inc. (US) 2016-05-11 EP disclosed
WO-2015002994-A2 HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-01-08 WO disclosed